Copyright
©The Author(s) 2019.
World J Gastroenterol. Nov 14, 2019; 25(42): 6322-6341
Published online Nov 14, 2019. doi: 10.3748/wjg.v25.i42.6322
Published online Nov 14, 2019. doi: 10.3748/wjg.v25.i42.6322
Table 4 Imaging characteristics of hepatocellular carcinoma cases
| Variable | n (%) | |
| Size in cm, mean ± SD (range) | 7.41 ± 3.137 (3.2-14) | |
| Portal vein tumor thrombosis | Yes | 35 (17.5) |
| No | 165 (82.5) | |
| Number of focal lesions | Single | 25 (12.5) |
| Multiple | 175 (87.5) | |
| Site of focal lesions | Right lobe | 112 (56.0) |
| Left lobe | 60 (30.0) | |
| Both lobes | 28 (14.0) | |
| BCLC stage | A | 25 (12.5) |
| B | 81 (40.5) | |
| C | 94 (47.0) |
- Citation: Elemeery MN, Mohamed MA, Madkour MA, Shamseya MM, Issa NM, Badr AN, Ghareeb DA, Pan CH. MicroRNA signature in patients with hepatocellular carcinoma associated with type 2 diabetes. World J Gastroenterol 2019; 25(42): 6322-6341
- URL: https://www.wjgnet.com/1007-9327/full/v25/i42/6322.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i42.6322